The ROE as of September 2024 (TTM) for NuCana plc (NCNA) is -222.84%

According to NuCana plc’s latest financial reports and current stock price. The company's current ROE is -222.84%. This represents a change of 167.07% compared to the average of -83.44% of the last 4 quarters.

NuCana plc (NCNA) Historical ROE (quarterly & annually)

How has NCNA ROE performed in the past?

The mean historical ROE of NuCana plc over the last ten years is -49.66%. The current -222.84% ROE has changed 348.76% with respect to the historical average. Over the past ten years (40 quarters), NCNA's ROE was at its highest in in the June 2016 quarter at 0%. The ROE was at its lowest in in the March 2017 quarter at -6485.48%.

NuCana plc (NCNA) ROE by Quarter and Year

Discovering the peaks and valleys of NuCana plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NuCana plc (NCNA) Average ROE

How has NCNA ROE performed in the past?

The current ROE of NuCana plc (NCNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NuCana plc (NCNA) ROE vs. Peers

How is NCNA’s ROE compared to its peers?

NuCana plc’s ROE is less than eFFECTOR Therapeutics, Inc. (0%), less than Virios Therapeutics, Inc. (2.18%), greater than Zura Bio Limited (-130.35%), greater than Navidea Biopharmaceuticals, Inc. (-35.45%), greater than ZyVersa Therapeutics, Inc. (-63.06%), greater than Cidara Therapeutics, Inc. (-172.51%), greater than Silence Therapeutics plc (-401.89%), greater than Applied Therapeutics, Inc. (-58.66%), greater than CytomX Therapeutics, Inc. (-577.92%), greater than Rani Therapeutics Holdings, Inc. (-27.44%), less than Vincerx Pharma, Inc. (0%), greater than Tenaya Therapeutics, Inc. (-300.92%), greater than Corvus Pharmaceuticals, Inc. (-276.65%), greater than ALX Oncology Holdings Inc. (-80.97%), greater than Mereo BioPharma Group plc (-53.99%), greater than Acumen Pharmaceuticals, Inc. (-946.88%), greater than Day One Biopharmaceuticals, Inc. (-63.39%), greater than Inozyme Pharma, Inc. (-24.63%), greater than Galera Therapeutics, Inc. (-122.70%), greater than null (-68.93%), less than null (21.95%),

Build a custom stock screener for NuCana plc (NCNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuCana plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NuCana plc (NCNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NuCana plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.